{"Clinical Trial ID": "NCT01216319", "Intervention": ["INTERVENTION 1:", "\u2022 Nipple reconstruction cylinder", "\u2022 Nipple reconstruction: Biodesign\u00ae nipple reconstruction cylinder"], "Eligibility": ["Incorporation criteria:", "The patient has a history of breast cancer, having already completed the removal and reconstruction of the unilateral or bilateral breast.", "The patient has a desire for the reconstruction of the nipple", "The patient is at least 18 years of age.", "And other inclusion criteria", "- Exclusion criteria:", "The patient is not medically fit for surgery under local anaesthesia.", "Currently, the patient smokes, uses tobacco or nicotine products (patch, gum or nasal spray).", "The patient is pregnant, breast-feeding or is planning to become pregnant later during the study period.", "The patient suffers from physical allergies or cultural objections to receiving pig products.", "And other exclusion criteria"], "Results": ["Performance measures:", "Percentage projection of nipple at 12 months from baseline (1 week after procedure)", "[Unspecified]", "Time limit: 12 months", "Results 1:", "Title of the arm/group: Nipple reconstruction cylinder", "Description of the arm/group : Nipple reconstruction : Biodesign nipple reconstruction cylinder", "Total number of participants analysed: 44", "Total number of units analysed", "Type of units Analysis: Nipples Average (standard deviation)Unity of measurement: percentage of projection against baseline: 37.3 (17.5)"], "Adverse Events": ["Undesirable Events 1:", "Total: 1/50 (2.0%)", "Metastatic breast cancer 1/50 (2.0%)"]}